Antithrombotic and antiplatelet activities of pelargonidin in vivo and in vitro

Archives of Pharmacal Research

Volumn 39, Issue 3, 2016, Pages 398-408

  Ku, Sae Kwang ^a   Yoon, Eun Kyung ^b   Lee, Wonhwa ^b,c   Kwon, Sinae ^b   Lee, Taeho ^b   Bae, Jong Sup ^b  

^a Daegu Haany University   (South Korea)

^b Kyungpook National University   (South Korea)

^c Kyungpook National University School of Medicine   (South Korea)

Author keywords

Anticoagulation; Antiplatelets; Endothelium; Fibrinolysis; Pelargonidin

Indexed keywords

PELARGONIDIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; THROMBIN; TISSUE PLASMINOGEN ACTIVATOR; ANTHOCYANIN; ANTICOAGULANT AGENT; BLOOD CLOTTING FACTOR 10A; FIBRIN; PELARGONIDIN-3-GLUCOSIDE;

ADULT; ANIMAL EXPERIMENT; ANTICOAGULATION; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; FIBRIN POLYMERIZATION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; NORMAL HUMAN; PARTIAL THROMBOPLASTIN TIME; PROTHROMBIN TIME; THROMBOCYTE AGGREGATION; UMBILICAL VEIN ENDOTHELIAL CELL; ANIMAL; BIOSYNTHESIS; BLEEDING TIME; BLOOD CLOTTING; CELL CULTURE; CELL SURVIVAL; DRUG EFFECTS; METABOLISM;

ANIMALS; ANTHOCYANINS; ANTICOAGULANTS; BLEEDING TIME; BLOOD COAGULATION; CELL SURVIVAL; CELLS, CULTURED; FACTOR XA; FIBRIN; HUMANS; MALE; MICE; PLASMINOGEN ACTIVATOR INHIBITOR 1; PLATELET AGGREGATION; THROMBIN; TISSUE PLASMINOGEN ACTIVATOR;

EID: 84954350015     PISSN: 02536269     EISSN: 19763786     Source Type: Journal    
DOI: 10.1007/s12272-016-0708-x     Document Type: Article

References (54)

1. Bae JS, Lee W, Nam JO, Kim JE, Kim SW, Kim IS (2014) Transforming growth factor beta-induced protein promotes severe vascular inflammatory responses. Am J Respir Crit Care Med 189:779-786
2. Bauer KA (2013) Pros and cons of new oral anticoagulants. Hematology Am Soc Hematol Educ Program 2013:464-470
3. Beecher GR (2003) Overview of dietary flavonoids: nomenclature, occurrence and intake. J Nutr 133:3248S-3254S
4. Beretz A, Cazenave JP, Anton R (1982) Inhibition of aggregation and secretion of human platelets by quercetin and other flavonoids: structure-activity relationships. Agents Actions 12:382-387
5. Dahlback B (2000) Blood coagulation. Lancet 355:1627-1632
6. Davie EW (1995) Biochemical and molecular aspects of the coagulation cascade. Thromb Haemost 74:1-6
7. Davie EW, Fujikawa K, Kisiel W (1991) The coagulation cascade: initiation, maintenance, and regulation. Biochemistry 30:10363-10370
8. Despotis GJ, Gravlee G, Filos K, Levy J (1999) Anticoagulation monitoring during cardiac surgery: a review of current and emerging techniques. Anesthesiology 91:1122-1151
9. Diehl KH, Hull R, Morton D, Pfister R, Rabemampianina Y, Smith D, Vidal JM, van de Vorstenbosch C (2001) A good practice guide to the administration of substances and removal of blood, including routes and volumes. J Appl Toxicol 21:15-23
10. Esmon CT (2005) The interactions between inflammation and coagulation. Br J Haematol 131:417-430
11. Fares A (2013) Winter cardiovascular diseases phenomenon. N Am J Med Sci 5:266-279
12. Franke B, Akkerman JW, Bos JL (1997) Rapid Ca2 + -mediated activation of Rap1 in human platelets. EMBO J 16:252-259
13. Fukumoto LR, Mazza G (2000) Assessing antioxidant and prooxidant activities of phenolic compounds. J Agric Food Chem 48:3597-3604
14. Furie B, Furie BC (2005) Thrombus formation in vivo. J Clin Invest 115:3355-3362
15. Ghosh S, Ezban M, Persson E, Pendurthi U, Hedner U, Rao LV (2007) Activity and regulation of factor VIIa analogs with increased potency at the endothelial cell surface. J Thromb Haemost 5:336-346
16. Hamaguchi E, Takamura T, Shimizu A, Nagai Y (2003) Tumor necrosis factor-alpha and troglitazone regulate plasminogen activator inhibitor type 1 production through extracellular signal-regulated kinase- and nuclear factor-kappaB-dependent pathways in cultured human umbilical vein endothelial cells. J Pharmacol Exp Ther 307:987-994
17. Hamalainen M, Nieminen R, Vuorela P, Heinonen M, Moilanen E (2007). Anti-Inflammatory Effects of Flavonoids: Genistein, Kaempferol, Quercetin, and Daidzein Inhibit STAT-1 and NF-kB Activations, Whereas Flavone, Isorhamnetin, Naringenin, and Pelargonidin Inhibit only NF-kB Activation along with Their Inhibitory Effect on iNOS Expression and NO Production in Activated Macrophages-Volume 2007, Article ID 45673. Mediators of Inflammation
18. Hidalgo M, Martin-Santamaria S, Recio I, Sanchez-Moreno C, de Pascual-Teresa B, Rimbach G, de Pascual-Teresa S (2012) Potential anti-inflammatory, anti-adhesive, anti/estrogenic, and angiotensin-converting enzyme inhibitory activities of anthocyanins and their gut metabolites. Genes Nutr 7:295-306
19. Hirsh J, Raschke R, Warkentin TE, Dalen JE, Deykin D, Poller L (1995) Heparin: mechanism of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety. Chest 108:258S-275S
20. Jauch EC, Saver JL, Adams HP Jr, Bruno A, Connors JJ, Demaerschalk BM, Khatri P, McMullan PW Jr, Qureshi AI, Rosenfield K, Scott PA, Summers DR, Wang DZ, Wintermark M, Yonas H (2013) Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 44:870-947
21. Kamei H, Kojima T, Hasegawa M, Koide T, Umeda T, Yukawa T, Terabe K (1995) Suppression of tumor cell growth by anthocyanins in vitro. Cancer Invest 13:590-594
22. Kamenickova A, Anzenbacherova E, Pavek P, Soshilov AA, Denison MS, Anzenbacher P, Dvorak Z (2013) Pelargonidin activates the AhR and induces CYP1A1 in primary human hepatocytes and human cancer cell lines HepG2 and LS174T. Toxicol Lett 218:253-259
23. Kang SY, Seeram NP, Nair MG, Bourquin LD (2003) Tart cherry anthocyanins inhibit tumor development in Apc(Min) mice and reduce proliferation of human colon cancer cells. Cancer Lett 194:13-19
24. Katsube N, Iwashita K, Tsushida T, Yamaki K, Kobori M (2003) Induction of apoptosis in cancer cells by Bilberry (Vaccinium myrtillus) and the anthocyanins. J Agric Food Chem 51:68-75
25. K-i Oyama, Kawaguchi S, Yoshida K, Kondo T (2007) Synthesis of pelargonidin 3-O-6″-O-acetyl-β-d-glucopyranoside, an acylated anthocyanin, via the corresponding kaempferol glucoside. Tetrahedron Lett 48:6005-6009
26. Kim TH, Ku SK, Bae JS (2012) Antithrombotic and profibrinolytic activities of eckol and dieckol. J Cell Biochem 113:2877-2883
27. Kong JM, Chia LS, Goh NK, Chia TF, Brouillard R (2003) Analysis and biological activities of anthocyanins. Phytochemistry 64:923-933
28. Ku SK, Bae JS (2014) Antiplatelet and antithrombotic activities of purpurogallin in vitro and in vivo. BMB Rep 47:376-381
29. Ku SK, Han MS, Lee MY, Lee YM, Bae JS (2014) Inhibitory effects of oroxylin A on endothelial protein C receptor shedding in vitro and in vivo. BMB Rep 47:336-341
30. Ku SK, Lee W, Kang M, Bae JS (2015) Antithrombotic activities of aspalathin and nothofagin via inhibiting platelet aggregation and FIIa/FXa. Arch Pharm Res 38:1080-1089
31. Lee KH (2000) Research and future trends in the pharmaceutical development of medicinal herbs from Chinese medicine. Public Health Nutr 3:515-522
32. Lee W, Ku SK, Bae JS (2015) Antiplatelet, anticoagulant, and profibrinolytic activities of baicalin. Arch Pharm Res 38:893-903
33. Lopez S, Peiretti F, Bonardo B, Juhan-Vague I, Nalbone G (2000) Effect of atorvastatin and fluvastatin on the expression of plasminogen activator inhibitor type-1 in cultured human endothelial cells. Atherosclerosis 152:359-366
34. Marin L, Miguelez EM, Villar CJ, Lombo F (2015) Bioavailability of dietary polyphenols and gut microbiota metabolism: antimicrobial properties. Biomed Res Int 2015:905215
35. Noda Y, Kaneyuki T, Mori A, Packer L (2002) Antioxidant activities of pomegranate fruit extract and its anthocyanidins: delphinidin, cyanidin, and pelargonidin. J Agric Food Chem 50:166-171
36. Nowak P, Zbikowska HM, Ponczek M, Kolodziejczyk J, Wachowicz B (2007) Different vulnerability of fibrinogen subunits to oxidative/nitrative modifications induced by peroxynitrite: functional consequences. Thromb Res 121:163-174
37. Oldoni TLC, Melo PS, Massarioli AP, Moreno IAM, Bezerra RMN, Rosalen PL, da Silva GVJ, Nascimento AM, Alencar SM (2016) Bioassay-guided isolation of proanthocyanidins with antioxidant activity from peanut (Arachis hypogaea) skin by combination of chromatography techniques. Food Chem 192:306-312
38. Paredes-Lopez O, Cervantes-Ceja ML, Vigna-Perez M, Hernandez-Perez T (2010) Berries: improving human health and healthy aging, and promoting quality life-a review. Plant Foods Hum Nutr 65:299-308
39. Pereira MS, Melo FR, Mourao PA (2002) Is there a correlation between structure and anticoagulant action of sulfated galactans and sulfated fucans? Glycobiology 12:573-580
40. Philip-Joet F, Alessi MC, Philip-Joet C, Aillaud M, Barriere JR, Arnaud A, Juhan-Vague I (1995) Fibrinolytic and inflammatory processes in pleural effusions. Eur Respir J 8:1352-1356
41. Quinn C, Hill J, Hassouna H (2000) A guide for diagnosis of patients with arterial and venous thrombosis. Clin Lab Sci 13:229-238
42. Rao LV, Rapaport SI, Lorenzi M (1988) Enhancement by human umbilical vein endothelial cells of factor Xa-catalyzed activation of factor VII. Blood 71:791-796
43. Ruggeri ZM (2002) Platelets in atherothrombosis. Nat Med 8:1227-1234
44. Schleef RR, Bevilacqua MP, Sawdey M, Gimbrone MA Jr, Loskutoff DJ (1988) Cytokine activation of vascular endothelium. Effects on tissue-type plasminogen activator and type 1 plasminogen activator inhibitor. J Biol Chem 263:5797-5803
45. Schmitt E, Stopper H (2001) Estrogenic activity of naturally occurring anthocyanidins. Nutr Cancer 41:145-149
46. Schouten M, Wiersinga WJ, Levi M, van der Poll T (2008) Inflammation, endothelium, and coagulation in sepsis. J Leukoc Biol 83:536-545
47. Sim D, Flaumenhaft R, Furie B (2005) Interactions of platelets, blood-borne tissue factor, and fibrin during arteriolar thrombus formation in vivo. Microcirculation 12:301-311
48. Sugo T, Nakamikawa C, Tanabe S, Matsuda M (1995) Activation of prothrombin by factor Xa bound to the membrane surface of human umbilical vein endothelial cells: its catalytic efficiency is similar to that of prothrombinase complex on platelets. J Biochem 117:244-250
49. Tijburg LBM, Mattern T, Folts JD, Weisgerber UM, Katan MB (1997) Tea flavonoids and cardiovascular diseases: a review. Crit Rev Food Sci Nutr 37:771-785
50. Tsuda T, Horio F, Osawa T (1998) Dietary cyanidin 3-O-beta-D-glucoside increases ex vivo oxidation resistance of serum in rats. Lipids 33:583-588
51. Wang H, Cao G, Prior RL (1997) Oxygen radical absorbing capacity of anthocyanins. J Agric Food Chem 45:304-309
52. Weitz JI, Hirsh J, Samama MM (2004) New anticoagulant drugs: the Seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest 126:265S-286S
53. Wells PS, Forgie MA, Rodger MA (2014) Treatment of venous thromboembolism. JAMA 311:717-728
54. Zhu Z, Kuang M, Lamikanra O, Liu G, Li S, He J (2015) Preparation and toxicological evaluation of methyl pyranoanthocyanin. Food Chem Toxicology. 83:125-132